強生*

-0.40 (-1.59%)最後更新 2026-09-11

台灣 · 上櫃 · 生技醫療業

24.80108成交張數25.31本益比1.30股價淨值比2.11%殖利率2026-09-11資料日期

ROE 與 ROA

近四季合計;近十年

每股淨值

元

負債比率

負債總額 / 資產總額

現金流量

單季,億元;自由現金流 = 營業現金流 + 資本支出(負值)

季度	資產總額(億)	母公司權益(億)	負債比率	流動比率	每股淨值	ROE(近四季)	ROA(近四季)	營業現金流(億)	自由現金流(億)
2026Q2	26	17	32.1%	0.74	19.12	5.3%	3.9%	0.1	0.0
2026Q1	31	18	42.5%	1.04	19.49	5.6%	3.9%	-0.2	-0.3
2025Q4	21	17	18.4%	3.79	18.83	3.1%	2.6%	0.1	-0.1
2025Q3	20	17	14.1%	4.76	19.01	4.5%	3.9%	0.2	-0.0
2025Q2	20	17	16.7%	4.08	18.55	4.9%	4.1%	0.0	-0.1
2025Q1	20	17	13.1%	7.97	19.22	5.0%	4.3%	0.4	0.3
2024Q4	20	17	13.3%	7.81	18.96	5.0%	4.3%	0.2	0.2
2024Q3	19	17	13.4%	7.65	18.74	5.0%	4.2%	0.2	0.1
2024Q2	20	17	17.3%	5.34	18.50	6.1%	4.4%	0.1	0.1
2024Q1	20	17	14.3%	6.96	19.05	6.0%	5.1%	0.2	0.1
2023Q4	20	17	16.1%	6.18	19.14	6.3%	5.3%	0.4	0.2
2023Q3	20	16	18.5%	6.67	19.93	6.6%	5.4%	0.5	0.4
2023Q2	15	9	40.1%	3.80	15.12	9.5%	6.5%	0.2	0.2
2023Q1	11	9	15.4%	2.64	14.95	8.5%	7.2%	0.3	0.2
2022Q4	10	9	16.1%	2.47	14.52	7.5%	6.3%	0.2	0.2
2022Q3	10	9	16.0%	2.41	14.18	6.9%	5.8%	0.3	0.0
2022Q2	10	8	19.6%	2.12	13.87	6.4%	5.2%	0.2	0.0
2022Q1	10	9	14.3%	2.93	14.28	5.9%	5.0%	0.1	0.0
2021Q4	10	8	17.4%	2.50	14.13	5.8%	4.6%	0.1	0.1
2021Q3	10	8	17.6%	2.40	14.04	5.9%	4.7%	0.3	0.2
2021Q2	10	8	16.8%	2.46	13.81	6.1%	5.0%	0.0	-0.1
2021Q1	11	9	17.5%	2.62	14.53	6.4%	5.5%	0.1	-0.1
2020Q4	11	9	21.9%	2.27	14.29	7.4%	6.2%	0.1	0.1
2020Q3	11	8	22.6%	2.19	14.04	8.6%	7.1%	-0.0	-1.5
2020Q2	10	8	18.3%	3.17	13.94	8.6%	7.2%	0.4	0.3
2020Q1	10	9	10.7%	5.39	14.41	7.9%	7.0%	0.2	0.2
2019Q4	10	8	10.9%	5.35	14.12	7.6%	6.8%	0.3	0.2
2019Q3	9	8	10.2%	5.57	13.81	7.4%	6.5%	0.1	0.0
2019Q2	10	8	15.3%	3.82	13.60	7.2%	6.1%	0.1	0.0
2019Q1	10	9	11.2%	5.37	14.21	6.9%	6.2%	0.3	0.2
2018Q4	9	8	10.7%	5.66	13.93	6.9%	6.1%	0.0	-0.0
2018Q3	9	8	12.5%	4.87	13.70	6.6%	5.8%	0.1	0.1
2018Q2	10	8	16.6%	3.68	13.65	7.1%	5.8%	0.3	0.3
2018Q1	9	9	7.5%	8.44	14.39	6.7%	6.1%	0.2	0.2
2017Q4	9	8	10.3%	6.18	13.92	7.2%	6.4%	0.2	0.1
2017Q3	9	8	11.2%	5.67	13.67	7.5%	6.7%	-0.1	-0.1
2017Q2	10	8	18.4%	3.46	13.42	7.2%	5.9%	0.2	0.2
2017Q1	9	8	10.0%	6.62	14.13	7.1%	6.4%	0.1	0.1
2016Q4	10	8	12.9%	5.04	13.86	–	–	0.1	0.1
2016Q3	9	8	11.3%	5.78	13.59	–	–	-0.0	-0.0